Castleark Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $325K | Sell |
|
|||||
2025
Q1 | $22.8M | Buy |
|
|||||
2024
Q4 | $18.7M | Sell |
|
|||||
2024
Q3 | $38.5M | Buy |
|
|||||
2024
Q2 | $21.9M | Buy |
|
|||||
2024
Q1 | $305K | Hold |
|
|||||
2023
Q4 | $297K | Hold |
|
|||||
2023
Q3 | $254K | Hold |
|
|||||
2023
Q2 | $257K | Hold |
|
|||||
2023
Q1 | $230K | Hold |
|
|||||
2022
Q4 | $211K | Hold |
|
|||||
2022
Q3 | $211K | Hold |
|
|||||
2022
Q2 | $206K | Hold |
|
|||||
2022
Q1 | $191K | Hold |
|
|||||
2021
Q4 | $160K | Hold |
|
|||||
2021
Q3 | $132K | Hold |
|
|||||
2021
Q2 | $147K | Hold |
|
|||||
2021
Q1 | $157K | Hold |
|
|||||
2020
Q4 | $173K | Sell |
|
|||||
2020
Q3 | $253K | Hold |
|
|||||
2020
Q2 | $270K | Sell |
|
|||||
2020
Q1 | $25M | Buy |
|
|||||
2019
Q4 | $14.6M | Buy |
|
|||||
2019
Q3 | $158K | Sell |
|
|||||
2019
Q2 | $2.04M | Sell |
|
|||||
2019
Q1 | $4.93M | Hold |
|
|||||
2018
Q4 | $4.45M | Hold |
|
|||||
2018
Q3 | $5.17M | Hold |
|
|||||
2018
Q2 | $4.56M | Hold |
|
|||||
2018
Q1 | $4.37M | Hold |
|
|||||
2017
Q4 | $4.02M | Hold |
|
|||||
2017
Q3 | $4.08M | Hold |
|
|||||
2017
Q2 | $3.46M | Hold |
|
|||||
2017
Q1 | $2.93M | Hold |
|
|||||
2016
Q4 | $1.98M | Hold |
|
|||||
2016
Q3 | $2.34M | Hold |
|
|||||
2016
Q2 | $2.31M | Hold |
|
|||||
2016
Q1 | $2.13M | Hold |
|
|||||
2015
Q4 | $3.38M | Sell |
|
|||||
2015
Q3 | $3.21M | Hold |
|
|||||
2015
Q2 | $3.81M | Hold |
|
|||||
2015
Q1 | $3.64M | Hold |
|
|||||
2014
Q4 | $3.66M | Sell |
|
|||||
2014
Q3 | $2.25M | Hold |
|
|||||
2014
Q2 | $3.01M | Hold |
|
|||||
2014
Q1 | $2.25M | Hold |
|
|||||
2013
Q4 | $2.37M | Buy |
|
|||||
2013
Q3 | $3.46M | Sell |
|
|||||
2013
Q2 | $2.99M | Buy |
|